Cubist Systematic Strategies’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$63.4K	Sell	37,485 -397,774	-91%	-$471K	﹤0.01%	2829
2025 Q2	$395K	Buy	+435,259	New	+$258K	﹤0.01%	2341
2023 Q2	–	Sell	-30,155	Closed	-$45.2K	–	3967
2023 Q1	$45.2K	Buy	30,155 +5,678	+23%	+$7.92K	﹤0.01%	3581
2022 Q4	$28.6K	Sell	24,477 -13,634	-36%	-$17.2K	﹤0.01%	3967
2022 Q3	$43K	Sell	38,111 -50,663	-57%	-$74.4K	﹤0.01%	4148
2022 Q2	$140K	Buy	+88,774	New	+$117K	﹤0.01%	3846
2021 Q3	–	Sell	-47,500	Closed	-$135K	–	3068
2021 Q2	$135K	Sell	47,500 -96,200	-67%	-$249K	﹤0.01%	2671
2021 Q1	$338K	Buy	+143,700	New	+$345K	﹤0.01%	2187
2020 Q4	–	Sell	-91,806	Closed	-$86K	–	2640
2020 Q3	$86K	Buy	+91,806	New	+$81.1K	﹤0.01%	2306